108 related articles for article (PubMed ID: 23264942)
1. New Stability-Indicating RP-UFLC Method for Determination of Trospium Chloride in Tablet Dosage Form.
Panda SS; Ravi Kumar BV; Mohanta G; Dash R; Patel PK
Sci Pharm; 2012; 80(4):955-64. PubMed ID: 23264942
[TBL] [Abstract][Full Text] [Related]
2. New Stability-Indicating RP-HPLC Method for Determination of Diclofenac Potassium and Metaxalone from their Combined Dosage Form.
Panda SS; Patanaik D; Ravi Kumar BV
Sci Pharm; 2012; 80(1):127-37. PubMed ID: 22396909
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a stability indicating UPLC method for determination of ticlopidine hydrochloride in its tablet formulation.
Ram V; Kher G; Dubal K; Dodiya B; Joshi H
Saudi Pharm J; 2011 Jul; 19(3):159-64. PubMed ID: 23960754
[TBL] [Abstract][Full Text] [Related]
4. Determination of Cephalexin Monohydrate in Pharmaceutical Dosage Form by Stability-Indicating RP-UFLC and UV Spectroscopic Methods.
Panda SS; Ravi Kumar BV; Dash R; Mohanta G
Sci Pharm; 2013; 81(4):1029-41. PubMed ID: 24482771
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a stability-indicating column high-performance liquid chromatographic assay method for determination of nebivolol in tablet formulation.
Kachhadia PK; Doshi AS; Joshi HS
J AOAC Int; 2008; 91(3):557-61. PubMed ID: 18567301
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a stability-indicating HPLC assay method for simultaneous determination of spironolactone and furosemide in tablet formulation.
Ram VR; Dave PN; Joshi HS
J Chromatogr Sci; 2012 Sep; 50(8):721-6. PubMed ID: 22641089
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a high-performance liquid chromatographic method for determination of eprosartan in bulk drug and tablets.
Patel HU; Suhagia BN; Patel CN
J AOAC Int; 2010; 93(6):1862-7. PubMed ID: 21313813
[TBL] [Abstract][Full Text] [Related]
8. Stability-indicating liquid chromatographic method for the quantification of the new antipsychotic agent asenapine in bulk and in pharmaceutical formulation.
Chhalotiya UK; Bhatt KK; Shah DA; Patel JR
Sci Pharm; 2012; 80(2):407-17. PubMed ID: 22896826
[TBL] [Abstract][Full Text] [Related]
9. Stability-Indicating RP-HPLC Method for the Determination of Ambrisentan and Tadalafil in Pharmaceutical Dosage Form.
Patel JK; Patel NK
Sci Pharm; 2014; 82(4):749-63. PubMed ID: 26279975
[TBL] [Abstract][Full Text] [Related]
10. Method Development and Validation of a Stability-Indicating RP-HPLC Method for the Quantitative Analysis of Dronedarone Hydrochloride in Pharmaceutical Tablets.
Dabhi B; Jadeja Y; Patel M; Jebaliya H; Karia D; Shah A
Sci Pharm; 2013; 81(1):115-22. PubMed ID: 23641332
[TBL] [Abstract][Full Text] [Related]
11. Validated Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Azelnidipine and Olmesartan in Their Combined Dosage Form.
Patel JK; Patel NK
Sci Pharm; 2014; 82(3):541-54. PubMed ID: 25853066
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Stability-Indicating RP-HPLC Method for the Assay of Pristinamycin in Bulk and Tablet Dosage Form.
Mallikarjuna Rao N; Gowrisankar D
Sci Pharm; 2016; 84(2):279-87. PubMed ID: 27222604
[TBL] [Abstract][Full Text] [Related]
13. Stress degradation studies and development of a validated stability-indicating-assay-method for determination of diacerein in presence of degradation products.
Hamrapurkar P; Patil P; Desai M; Phale M; Pawar S
Pharm Methods; 2011 Jan; 2(1):30-5. PubMed ID: 23781427
[TBL] [Abstract][Full Text] [Related]
14. Optimization of forced degradation using experimental design and development of a stability-indicating liquid chromatographic assay method for rebamipide in bulk and tablet dosage form.
Sonawane S; Gide P
Sci Pharm; 2011; 79(1):85-96. PubMed ID: 21617774
[TBL] [Abstract][Full Text] [Related]
15. A New Improved RP-HPLC Method for Assay of Rosuvastatin Calcium in Tablets.
Kaila HO; Ambasana MA; Thakkar RS; Saravaia HT; Shah AK
Indian J Pharm Sci; 2010 Sep; 72(5):592-8. PubMed ID: 21694991
[TBL] [Abstract][Full Text] [Related]
16. STABILITY-INDICATING HPLC METHOD FOR DETERMINATION OF VANCOMYCIN HYDROCHLORIDE IN THE PHARMACEUTICAL DOSAGE FORMS.
Serri A; Moghimp HR; Mahboubi A; Zarghi A
Acta Pol Pharm; 2017 Jan; 74(1):73-79. PubMed ID: 29474763
[TBL] [Abstract][Full Text] [Related]
17. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a stability indicating RP-HPLC method for the determination of Rufinamide.
Sai Pavan Kumar B; Mathrusri Annapurna M; Pavani S
J Pharm Anal; 2013 Feb; 3(1):66-70. PubMed ID: 29403798
[TBL] [Abstract][Full Text] [Related]
19. Validation of assay indicating method development of meloxicam in bulk and some of its tablet dosage forms by RP-HPLC.
Sahoo NK; Sahu M; Rao PS; Rani NS; Devi JI; Ghosh G
Springerplus; 2014; 3():95. PubMed ID: 24711980
[TBL] [Abstract][Full Text] [Related]
20. A developed and validated stability-indicating reverse-phase high performance liquid chromatographic method for determination of cefdinir in the presence of its degradation products as per International Conference on Harmonization guidelines.
Hamrapurkar P; Patil P; Phale M; Gandhi M; Pawar S
Pharm Methods; 2011 Jan; 2(1):15-20. PubMed ID: 23781424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
